Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1975-1979  (2)
  • Phencyclidine  (2)
  • Affective disorder
  • chlorpromazine
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Acta neuropathologica 45 (1979), S. 83-95 
    ISSN: 1432-0533
    Keywords: Myofibril ; Myopathy ; Phencyclidine ; Restraint ; Mitochondria
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The distribution of myopathic changes produced by phencyclidine (PCP) and restraint was studied in the diaphragm and 6 lower limb muscles of the rat. Fiber-type composition and muscle location did not correlate with the degree of injury; but muscle activity in restraint did correlate. The predominant lesion produced was extensive myofibrillar disruption, which was the only lesion temporally related to the increased plasma creatine phosphokinase (CPK) activity that begins within minutes of treatment. Early on, disoriented, structurally abnormal mitochondria were localized to foci of disrupted myofibrils, but they were absent in such areas at 24h. Significant Z-band smearing, accompanied by focal mitochondrial absence, was first noted at 24h. In untreated control muscles, Z-band smearing occurred predominantly in the soleus but was not limited to that muscle. The occurrence of Z-band smearing was related to the proportion of mitochondrial-rich fibers in control specimens. On the contrary, the occurrence of myofibrillar disruption was related to the proportion of mitochondrial-poor fibers in the control specimens. In both experimental and control muscle, Z-band smearing occurred predominantly in those specially differentiated peripheral areas in the muscle fiber which are immediately adjacent to transversely coursing blood vessels. These areas normally lack mitochondria. Thus, the mitochondrial absence in areas of Z-band smearing is not of the same significance as the focal mitochondrial loss that occurs in areas of myofibrillar disruption. These findings may apply to the pathogenesis of myofibrillar lesions in general.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-2072
    Keywords: Isometric Muscle Tension ; Plasma Creatine Phosphokinase ; Muscle Damage ; Sernyl ; Phencyclidine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract A restraint cage with a strain gauge attached to a movable roof to record the isometric force exerted by rats during restraint is described. The isometric activity score, an integral of the total upward force exerted during restraint, correlated significantly with plasma creatine phosphokinase (CPK) activity in rats following restraint. Phencyclidine 5 mg/kg administered intraperitoneally to rats 15 min prior to 1/2 hr restraint has been shown to produce muscle damage associated with large increases of plasma CPK activity. Dose-response curves for the effects of phencyclidine on isometric activity score and plasma CPK activity were essentially parallel, and isometric activity scores were linearly related to plasma CPK activity. Rats restrained and painfully stimulated on the tail developed both elevated isometric activity scores and elevations of plasma CPK activity. Slopes of the curves relating isometric activity to plasma CPK activity were identical for painfully stimulated and phencyclidine treated rats. Phencyclidine has been reported to produce large increases in locomotor activity in unrestrained rats without muscle damage or elevated plasma CPK activity. Thus, increased isometric muscle tension developed during phencyclidine plus restraint is related to the production of muscle damage and increased efflux of CPK in rats.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...